Angiogenesis: BFGF and VEGF in breast carcinoma

Archive of Oncology

Volumn 14, Issue 3-4, 2006, Pages 126-130

  Vujasinović, Tijana ^a   Buta, Marko ^a   Markićević, Milan ^a   Nikolić Vukosavljević, Dragica ^a  

^a INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

Author keywords

Angiogenesis inducing agents; Breast neoplasms; Fibroblast growth factor 2; Neovascularisation, pathologic; Vascular endothelial growth factors

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; VASCULOTROPIN;

ANGIOGENESIS; BASEMENT MEMBRANE; BREAST CARCINOMA; CANCER INVASION; EXTRACELLULAR MATRIX; HUMAN; LYMPHANGIOGENESIS; METASTASIS; PARACRINE SIGNALING; PROTEIN DEGRADATION; REVIEW; TUMOR GROWTH; TUMOR VASCULARIZATION;

EID: 34147138239     PISSN: 03547310     EISSN: None     Source Type: Journal    
DOI: 10.2298/AOO0604126V     Document Type: Review

References (27)

1. Gasparini G. Clinical significance of determination of surrogate markers of angiogenesis in breast cancer. Crit Rev Oncol/Hematol 2001;37:97-114.
2. Potgens A, Westphal H, De Waal R, Ruiter D. The Role of Vascular Permeability Factor and Basic Fibroblast Growth Factor in Tumor angiogenesis. Biol Chem Hoppe-Seyler 1995;376:57-70.
3. Presta M, Dell'Era P, Mitola S, Moroni E, Ronca R, Rusnati M. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine & Growth F Rev 2005;16:159-78.
4. Gasparini G, Harris AL. Clinical importance of determination of tumor angiogenesis in breast carcinoma: much more than prognostic tool. J Clin Onc 1995;13:765-83.
5. Harris AL. New developments in angiogenesis: a major mechanism for tumor growth and target for therapy. Cancer J Sci Am 1998;4:209-17.
6. Terman B, Stoletov K. VEGF and tumor angiogenesis. Einstein Quart. J Biol Med 2001;18:59-66.
7. Gasparini G. Editorial: Angiogenesis in preneoplastic and neoplastic lesions. Cancer J 1995;8:91-3.
8. Folkman J. Clinical applications of research on angiogenesis. N Engl J Med: Seminars in Medicine of the Beth Israel Hospital, Boston 1995;333:1757-63.
9. Miliaras D, Kamas A, Kalekou H. Angiogenesis in invasive breast carcinoma: is it associated with parameters of prognostic significance? Histopathology 1995;26:165-9.
10. Folkman J. Angiogenesis and apoptosis. Sem Cancer Biol 2003;13:159-67.
11. Dickson RB, Lippman ME. Molecular determinants of growth, angiogenesis and metastases in breast carcinoma. Sem Oncol 1992;19:286-98.
12. Dailey L, Ambrosetti D, Mansuakhani A, Basilico C. Mechanisms underlying differential responses to FGF signaling. Cytokine & Growth F Rev 2005;16:233-47.
13. Smith K, Fox SB, Whitehouse R, Taylor M, Greenall M, Clarke J, et al. Upregulation of bFGF in breast carcinoma and its relationship to vascular density, estrogen receptor, epidermal growth factor receptor and survival. Ann Oncol 1999;10:707-13.
14. Grose R, Dickson C. Fibroblast growth factor signaling in tumorigenesis. Cytokine & Growth Factor Rev 2005;16:179-86.
15. Yiangou C, Gomm JJ, Coope RC, Law M, Luqmani YA, Shousha S, et al. Fibroblast growth factor 2 in breast cancer: Occurrence and prognostic significance. Br J Cancer 1997;75:28-33.
16. Colomer R, Aparicio J, Montero S, Guzman C, Larrodera L, Cortes-Funes H. Low levels of bFGF are associated with poor prognosis in human breast carcinoma. Br J Cancer 1997;76:1215-20.
17. Relf M, LeJeune S, Scott PA, Fox S, Smith K, Harris AL, et al. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiothophin in human primary breast cancer and its relation to angiogenesis. Cancer Res 1997;57:963-9.
18. Faridi A, Rudlowski C, Biesterfeld S, Schuh S, Schroder W. Long-term follow-up and prognostic significance of angiogenic basic fibroblast growth factor (bFGF) expression in patients with breast cancer. Pathol Res Pract 2002;198(1):1-5.
19. Eppenberger U, Kueng W, Schlaeppi JM, John A Foekens, Eppenberger-Castor S, et al. Markers of Tumor angiogenesis and protelysis independently define high- and low- risk subsets of node negative breast cancer patients. J Clin Oncol 1998;16:3129-36.
20. Keping X, Wei D, Qian S, Huang S. Constitutive and inducible expression and regulation of vascular endothelial growth factor. Cytokine & Growth Factor Rev 2004;15:297-324.
21. Nagy JA, Vasile E, Feng D, Sundberg C, Brown LF, Detmar MJ, et al. Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J Exp Med 2002;196:1497-506.
22. Mercurio AM, Lipscomb EA, Bachelder RE. Non-angiogenic functions of VEGF in breast cancer. J Mamm Gland Biol Neoplasia 2005;10(4):283-90.
23. Garvin S, Nilsson UW, Huss FR, Kratz G, Dabrosin C. Estradiol increases VEGF in human breast studied by whole-tissue culture. Cell Tissue Res 2006;325(2):245-51.
24. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249-57.
25. Agnantis NJ, Goussia AC, Batistatou A, Stefanou D. Tumor markers in cancer patients: an update of their prognostic significance (part II). In Vivo 2004;18(4):481-8.
26. Stavri GT, Zachary IC, Baskerville PA, Martin JF, Erusalimsky JD. Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia. Circulation 1995;92:11-4.
27. Goldhirsch A, Glick J H, Gelber RD, Coates AS, Thurlimann B, Senn HJ & Panel Members. Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer. Ann Oncol 2005;16:1569-83.